Crisis intervention for adolescents who self-harm
Brief Admission by Self-referral for Adolescents Who Self-harm, at Risk for Suicide. A Qualitative Study to Optimise and Standardise the Intervention
This study is testing a new hospital program for teenagers who self-harm to see if it helps them feel more in control and improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 75 (estimated) |
| Ages | 13 Years to 100 Years |
| Sex | All |
| Sponsor | Region Skane Academic / other |
| Locations | 1 site (Lund, Skåne) |
| Trial ID | NCT04962373 on ClinicalTrials.gov |
What this trial studies
This study focuses on the Brief Admission (BA) approach for adolescents who engage in self-harm and are at risk for suicide. It aims to gather standardized information on the experiences of adolescents, their parents, and staff involved in the BA program, which emphasizes increased autonomy and self-care through voluntary hospital referrals. The study will utilize semi-structured interviews to collect qualitative data from participants to better understand the effectiveness of this intervention. The BA method has shown promise in adult populations and is being adapted for adolescent care in Skåne.
Who should consider this trial
Good fit: Ideal candidates include adolescents aged 13 and older who have an active BA contract and can provide consent.
Not a fit: Patients younger than 13 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could improve crisis management and support for adolescents experiencing self-harm and suicidal thoughts.
How similar studies have performed: While the BA method has been successful in adults, its adaptation for adolescents is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Sample 1: Inclusion Criteria: * Adolescents with an active BA contract * At least 13 years of age. * Able to consent to study participation through written and oral information. * Consent from caregivers * Given consent to participate Exclusion Criteria: * Below the age of 13. Sample 2: Inclusion Criteria: * Parents to adolescents with an active BA contract * At least 18 years of age. * Able to consent to study participation through written and oral information. * Given consent to participate Exclusion Criteria: * None Sample 3: Inclusion Criteria: * Staff working with adolescents with an active BA contract * At least 18 years of age. * Able to consent to study participation through written and oral information. * Given consent to participate Exclusion Criteria: * None
Where this trial is running
Lund, Skåne
- Psykiatri och habilitering, Region Skåne — Lund, Skåne, Sweden (Recruiting)
Study contacts
- Study coordinator: Sofie Westling, MD PhD
- Email: sofie.westling@med.lu.se
- Phone: +46735626099
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.